Ramm Pharma (TSE:RAMM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ramm Pharma Corp. has announced that the Ontario Superior Court of Justice has dismissed both the CAD 3,139,931.30 claim against them and their CAD 14,220,000 counterclaim in a legal dispute with Sergio Martines and Naturale Science Inc. The court did award a minor sum for unpaid expenses to Martines. Ramm continues its operations in cannabinoid pharmacology with a diversified portfolio in various international markets.
For further insights into TSE:RAMM stock, check out TipRanks’ Stock Analysis page.